Topics

Alembic Gets Sartans Shot In Q2

01:45 EDT 29 Oct 2019 | SCRIP

The continuing sartans crisis and new product launches in US helped Alembic to post a strong Q2 performance, despite slowdown...

      

Related Stories

 

Original Article: Alembic Gets Sartans Shot In Q2

NEXT ARTICLE

More From BioPortfolio on "Alembic Gets Sartans Shot In Q2"

Quick Search